B Charpentier

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Flavio Vincenti, B Charpentier, Yves Vanrenterghem et al. · American Journal of Transplantation · 2010 · 946 citations

Medicine, Nephrology, Pharmacology +15

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

Flavio Vincenti, Christian P. Larsen, Josefina Alberú et al. · American Journal of Transplantation · 2011 · 308 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Risk Factors and Long-Term Outcome of Transplant Renal Artery Stenosis in Adult Recipients After Treatment by Percutaneous Transluminal Angioplasty

Vincent Audard, Marie Matignon, F. Hémery et al. · American Journal of Transplantation · 2005 · 178 citations

Medicine, Nephrology, Surgery +17

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

Bernhard K. Krämer, B Charpentier, Lars Bäckman et al. · American Journal of Transplantation · 2010 · 166 citations · Full text

Medicine, Nephrology, Pharmacokinetics +12

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

Maurizio Salvadori, Klemens Budde, B Charpentier et al. · American Journal of Transplantation · 2006 · 147 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17